Analysis of brain activity and a specific marker in the blood can help detect these early alterations in individuals without symptoms. The study included 76 participants without cognitive impairment, of whom 54 had a family history of the disease.
From June 15 to 17, the Congress of the European Society of Ophthalmology 2023 was held in Prague and the Aragón Health Research Institute was present with a luxury representation.